130 related articles for article (PubMed ID: 31984217)
21. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
Reddy EP; Korapati A; Chaturvedi P; Rane S
Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth control by SOCS1 and SOCS3.
Khan MGM; Ghosh A; Variya B; Santharam MA; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2019 Sep; 121():154733. PubMed ID: 31154249
[TBL] [Abstract][Full Text] [Related]
23. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
24. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
25. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
26. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
27. SOCS proteins in development and disease.
Trengove MC; Ward AC
Am J Clin Exp Immunol; 2013; 2(1):1-29. PubMed ID: 23885323
[TBL] [Abstract][Full Text] [Related]
28. Differential roles of SOCS family members in EpoR signal transduction.
Jegalian AG; Wu H
J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
30. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
31. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
Chien H; Alston CI; Dix RD
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
[TBL] [Abstract][Full Text] [Related]
32. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
34. Dectin-1 stimulation induces suppressor of cytokine signaling 1, thereby modulating TLR signaling and T cell responses.
Eberle ME; Dalpke AH
J Immunol; 2012 Jun; 188(11):5644-54. PubMed ID: 22547696
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of cytokine signaling pathways.
Yasukawa H; Sasaki A; Yoshimura A
Annu Rev Immunol; 2000; 18():143-64. PubMed ID: 10837055
[TBL] [Abstract][Full Text] [Related]
36. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.
Yu CR; Mahdi RM; Ebong S; Vistica BP; Chen J; Guo Y; Gery I; Egwuagu CE
J Immunol; 2004 Jul; 173(2):737-46. PubMed ID: 15240659
[TBL] [Abstract][Full Text] [Related]
37. Understanding SOCS protein specificity.
Linossi EM; Calleja DJ; Nicholson SE
Growth Factors; 2018 Aug; 36(3-4):104-117. PubMed ID: 30318950
[TBL] [Abstract][Full Text] [Related]
38. Identification of a nuclear localization signal in suppressor of cytokine signaling 1.
Baetz A; Koelsche C; Strebovsky J; Heeg K; Dalpke AH
FASEB J; 2008 Dec; 22(12):4296-305. PubMed ID: 18725457
[TBL] [Abstract][Full Text] [Related]
39. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.
Jiang M; Zhang WW; Liu P; Yu W; Liu T; Yu J
Front Immunol; 2017; 8():70. PubMed ID: 28228755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
